Approval · Notice of Compliance 5390 · 1994
SALOFALK: Notice of Compliance 5390
Issued July 15, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5390
- Date
- July 15, 1994
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Lower gastrointestinal tract anti-inflammatory
Products in this notice
Medicinal ingredients
- MESALAZINE 250 MG per SUP
- MESALAZINE 500 MG per SUP
- MESALAZINE 2 G
- MESALAZINE 4 G